Fluorouracil

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 19.01.2022

Dieser Artikel auf Deutsch

Synonym(s)

5-fluorouracil; 5-FU

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Cytostatic drug which is widely used systemically (see Fluorouracil/Internal Medicine below) and locally in various forms of application and indications.

Half-lifeThis section has been translated automatically.

0,3–70 h

IndicationThis section has been translated automatically.

Topical in a 5% cream application for actinic keratoses and basal cell carcinomas after previous curettage (Efudix®). This treatment approach requires sufficient experience from both the therapist and the patient.

Topically used in a 0.5% concentration in combination with 10% salicylic acid for localized actinic keratoses and for field carcinogenesis with good success (Actikerall®).

Topically in a 0.5% solution in combination with 10% salicylic acid and DMSO as therapeutic agent for viral warts (Verrumal®).

Standard concentrationThis section has been translated automatically.

0.5-5% in creams, ointments and solutions on day 1, 3 and 5 after curettage, apply thinly and bandage.

Undesirable effectsThis section has been translated automatically.

Dermatitis with blistering; diffuse hair loss (in children) after prolonged local application with measurable levels of 5-fluorouracil in the blood (according to individual case reports). Transient hyperpigmentation often occurs with intralesional injections (e.g. keloids).

PreparationsThis section has been translated automatically.

Efudix®, 5-FU Hexal®, Tolak® 40 mg/g cream, Verrumal®.

LiteratureThis section has been translated automatically.

  1. Khandpur S et al (2003) Successful treatment of multiple premalignant and malignant lesions in arsenical keratosis with a combination of acitretin and intralesional 5-fluorouracil. J Dermatol 30: 730-734
  2. Nanda S et al (2004) Intralesional 5-fluorouracil as a treatment modality of keloids. Dermatol Surgery 30: 54-57
  3. Steffen C (2003) Topical 5-fluorouracil. Skinmed 2: 123-126
  4. Zamiri M et al (2003) Plantar warts treated with an immune response modifier: a report of two cases. Clin Exp Dermatol 28(Suppl1): 45-47

Authors

Last updated on: 19.01.2022